ATE530650T1 - Hochaffine antagonisten von elr-cxc-chemokinen - Google Patents

Hochaffine antagonisten von elr-cxc-chemokinen

Info

Publication number
ATE530650T1
ATE530650T1 AT07719770T AT07719770T ATE530650T1 AT E530650 T1 ATE530650 T1 AT E530650T1 AT 07719770 T AT07719770 T AT 07719770T AT 07719770 T AT07719770 T AT 07719770T AT E530650 T1 ATE530650 T1 AT E530650T1
Authority
AT
Austria
Prior art keywords
afffine
elr
antagonists
cxc chemokines
cxc
Prior art date
Application number
AT07719770T
Other languages
English (en)
Inventor
John R Gordon
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38693498&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE530650(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Application granted granted Critical
Publication of ATE530650T1 publication Critical patent/ATE530650T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT07719770T 2006-05-16 2007-05-16 Hochaffine antagonisten von elr-cxc-chemokinen ATE530650T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80040606P 2006-05-16 2006-05-16
PCT/CA2007/000848 WO2007131352A1 (en) 2006-05-16 2007-05-16 High-affinity antagonists of elr-cxc chemokines

Publications (1)

Publication Number Publication Date
ATE530650T1 true ATE530650T1 (de) 2011-11-15

Family

ID=38693498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07719770T ATE530650T1 (de) 2006-05-16 2007-05-16 Hochaffine antagonisten von elr-cxc-chemokinen

Country Status (15)

Country Link
US (1) US8039429B2 (de)
EP (1) EP2021475B1 (de)
JP (1) JP5462623B2 (de)
CN (1) CN101484579B (de)
AR (1) AR060960A1 (de)
AT (1) ATE530650T1 (de)
AU (1) AU2007250429A1 (de)
BR (1) BRPI0711589A2 (de)
CA (1) CA2652094A1 (de)
CL (1) CL2007001402A1 (de)
IL (1) IL195309A0 (de)
MX (1) MX2008014656A (de)
NZ (1) NZ573657A (de)
TW (1) TW200813084A (de)
WO (1) WO2007131352A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252741B2 (en) 2008-02-12 2012-08-28 Gordon John R Uses of modified ELR-CXC chemokine G31P
EP3011012B1 (de) 2013-06-18 2018-09-12 New York University Zelluläre faktoren in der zytotoxizität von staphylococcus-aureus-leukocidinen: neuartige therapeutische targets
CN103399151A (zh) * 2013-06-24 2013-11-20 上海交通大学医学院附属瑞金医院 Cxcl8细胞因子检测试剂在制备甲状腺***状癌的诊断试剂中的应用
CN104832798A (zh) * 2014-02-10 2015-08-12 欧司朗有限公司 Led照明装置
WO2018106959A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
WO2018112264A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
CN109022599A (zh) * 2018-10-08 2018-12-18 河南科技学院 检测奶牛CCL28基因单核苷酸多态性的试剂盒及RFLP方法及相关SNPs
WO2020106757A1 (en) 2018-11-19 2020-05-28 Progenity, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
US11707610B2 (en) 2019-12-13 2023-07-25 Biora Therapeutics, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840524A (en) 1992-11-27 1998-11-24 Stichting Rega Vzw Granulocyte chemotactic protein
ES2274957T3 (es) * 2001-03-01 2007-06-01 University Of Saskatchewan Technologies Inc. Antagonistas de elevada afinidad de quimiocinas cxc de elr.

Also Published As

Publication number Publication date
US20090270318A1 (en) 2009-10-29
IL195309A0 (en) 2011-08-01
CA2652094A1 (en) 2007-11-22
CN101484579B (zh) 2012-02-29
NZ573657A (en) 2011-09-30
CN101484579A (zh) 2009-07-15
EP2021475B1 (de) 2011-10-26
AU2007250429A1 (en) 2007-11-22
TW200813084A (en) 2008-03-16
EP2021475A1 (de) 2009-02-11
JP2009542192A (ja) 2009-12-03
US8039429B2 (en) 2011-10-18
AR060960A1 (es) 2008-07-23
MX2008014656A (es) 2009-01-30
EP2021475A4 (de) 2009-12-09
CL2007001402A1 (es) 2008-03-14
WO2007131352A1 (en) 2007-11-22
BRPI0711589A2 (pt) 2011-11-16
JP5462623B2 (ja) 2014-04-02

Similar Documents

Publication Publication Date Title
DK1720866T3 (da) Fremgangsmåde
DK1963369T3 (da) Il-21-antagonister
DK2228086T3 (da) Forstøver
DK1986650T3 (da) Manipulationssikre doserignsformer
RU2458924C3 (ru) Соединения замещенных диазепанов в качестве антагонистов орексиновых рецепторов
ATE530650T1 (de) Hochaffine antagonisten von elr-cxc-chemokinen
DK2094709T3 (da) Thiazol-pyrazolopyrimidiner som CRF1-receptorantagonister
ATE533744T1 (de) N-benzoypyrrolidin-3-ylamine als histamin-3 antagonisten
BRPI0718494A2 (pt) Derivado de fenilsulfamoil benzamida como antagonistas de bradicinina
DE602007013051D1 (de) Sprühvorrichtung
BRPI0718436A2 (pt) Novos derivados de benzamida como antagonistas da bradicina
BRPI0817835A2 (pt) Antagonistas cgrp
ATE512963T1 (de) Heterocyclen als orexinantagonisten
DE602007012260D1 (de) Nitratester von piperidinen
BRPI0908008A2 (pt) Farmacóforo dual - pde4-antagonistas muscarínicos
SE0601926L (sv) Kokkärl
BRPI0907519A2 (pt) Antagonistas farmacoforos-pde4-muscarínicos duais
ATE524972T1 (de) Poly-tlr-antagonist
ITMI20062202A1 (it) Struttura di dodina multiconnessione
DE502007004639D1 (de) Sprühdose
FI20065032A0 (fi) Menetelmä asbestialtistumiseen liittyvien keuhkosyöpien tunnistamiseksi
ITCA20060011A1 (it) Marmellata di pompia
UA13850S (uk) Набір столових приборів
UA14400S (uk) Посуд
UA15712S (uk) Ванна

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties